24
Participants
Start Date
March 31, 2011
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Regorafenib (BAY73-4506); Regorafenib (BAY73-4506) plus ketoconazole
Treatment 1: A single 160 mg dose of BAY73-4506. Treatment 2: Ketoconazole 400 mg once daily from Day -4 to Day 3. A single 160 mg dose of BAY73-4506 on Day 1.
Brighton
Lead Sponsor
Bayer
INDUSTRY